HLNE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Hamilton Lane Inc (HLNE) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is currently experiencing a bearish trend, with negative price momentum and no clear trading signals from Intellectia Proprietary Trading Signals. While the company has shown solid financial growth in Q3 2026 and has a new product launch (HLCIF) as a potential positive catalyst, market volatility, credit concerns, and recent price target downgrades from analysts suggest caution. The lack of significant insider or hedge fund activity, along with neutral options sentiment, further supports a hold recommendation.
The stock is in a bearish trend with moving averages indicating downward momentum (SMA_200 > SMA_20 > SMA_5). RSI is neutral at 37.044, and MACD is positive but contracting. Key support is at 96.323, and resistance is at 99.748. The stock closed at $97.53, with a pre-market drop of -1.49% and a regular market drop of -3.30%.
Strong Q3 financial performance with revenue up 27.39% YoY, net income up 10.19% YoY, and EPS up 3.79% YoY.
Launch of the Hamilton Lane Credit Income Fund (HLCIF), which could enhance private market access and attract new investors.
Recent price target downgrades from analysts citing credit issues, market volatility, and fraud allegations.
Bearish price momentum with significant recent declines (-3.30% regular market change).
No significant insider or hedge fund activity, indicating a lack of strong institutional confidence.
In Q3 2026, Hamilton Lane reported strong financial growth: Revenue increased by 27.39% YoY to $218.27M, net income increased by 10.19% YoY to $58.37M, and EPS rose by 3.79% YoY to $1.37. Gross margin remained unchanged.
Analyst sentiment is mixed but leaning negative recently. BMO Capital lowered its price target to $118 from $148, citing credit issues and market volatility. UBS also reduced its target to $150 from $184 but maintained a Buy rating. Earlier in the year, Oppenheimer and Morgan Stanley raised their targets, reflecting optimism, but recent downgrades dominate the sentiment.
